Is cognitive functioning detrimentally affected after early, induced menopause?

Menopause

Volumn 16, Issue 1, 2009, Pages 188-198

  Vearncombe, Katharine J ^a,b   Pachana, Nancy A ^b  

^a Wesley Research Institute   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Chemical menopause; Chemotherapy induced menopause; Cognition; Estrogen; Menopausal transition; Surgical menopause

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN; THIOTEPA; ANTINEOPLASTIC AGENT;

AMNESIA; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DRUG MEGADOSE; EARLY MENOPAUSE; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; MENOPAUSE; MULTIPLE CYCLE TREATMENT; OVARIECTOMY; REVIEW; VERBAL MEMORY; VISUAL MEMORY; ADULT; AGED; ESTROGEN THERAPY; FEMALE; MEDLINE; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COGNITION DISORDERS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYSTERECTOMY; MEDLINE; MENOPAUSE; MIDDLE AGED; OVARIECTOMY; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 64049086128     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181775eb4     Document Type: Review

References (52)

1. Asthana S. Estrogen and cognition: the story so far. J Gerontol A Biol Sci Med Sci 2003;58A:322-323.
2. Asthana S. Estrogen and cognition: a true relationship? J Am Geriatr Soc 2004;52:316-318.
3. Aveleyra E, Carranza-Lira S, Ulloa-Aguirre A, Ostrosky-Solis F. Cognitive effects of hormone therapy in early postmenopausal women. Int J Psychol 2005;40:314-332.
4. King R, Travers C, O'Neill S, Byrne G, Khoo SK. The influence of postmenopausal hormone replacement therapy on cognitive functioning: results from an observational study. J Br Menopause Soc 2004;10:103-107.
5. Kurt M, Bekci B, Karakas S. Hormone replacement therapy and cognitive function in postmenopausal women. Maturitas 2006;53:39-48.
6. Low L-F, Anstey KJ, Jorm AF, Christensen H, Rodgers B. Hormone replacement therapy and cognition in an Australian representative sample aged 60-64 years. Maturitas 2006;54:86-94.
7. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory study. JAMA 2004;291:2959-2968.
8. Farrag AF, Khedr EM, Abdel-Aleem H, Rageh TA. Effect of surgical menopause on cognitive functions. Dement Geriatr Cogn Disord 2002;13:193-198.
9. Shilling V, Jenkins V, Fallowfield L, Howell A. The effects of estrogen and anti-estrogens on cognition. Breast 2001;10:484-491.
10. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: a literature review. Menopause 2004;11:120-130.
11. Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause 2007;14:572-579.
12. Genant HK, Cann CE, Ettinger B, Gordan SG. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982;97:699-705.
13. Costa A, Nappi RE, Sinforiani E, Bono G, Poma A, Nappi G. Cognitive function at menopause: neuroendocrine implications for the study of the aging brain. Funct Neurol 1997;12:175-180.
14. Sherwin BB. Estrogen and-or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-357.
15. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
16. Sherwin BB, Phillips S. Estrogen and cognitive functioning in surgically menopausal women. Ann N Y Acad Sci 1990;592:474-475.
17. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-995.
18. Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 1998;91:459-466.
19. Walpurger V, Pietrowsky R, Djahansouzi S, Wolf OT. No changes in event-related potentials with estrogen or estrogen plus progesterone treatment in healthy older hysterectomized women: results from a double-blind, placebo-controlled study. Psychopharmacology 2005;179:652-661.
20. File SE, Heard JE, Rymer J. Trough estradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants. Psychopharmacology 2002;161:107-112.
21. Kritz-Silverstein D, Barrett-Connor E. Hysterectomy, oophorectomy and cognitive function in older women. J Am Geriatr Soc 2002;50:55-61.
22. Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav 1995;29:312-321.
23. Szklo M, Cerhan J, Diez-Roux AV, et al. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 1998;144:1048-1057.
24. Rice MM, Graves AB, McCurry SM, et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: the KAME project. Arch Intern Med 2000;160:1641-1649.
25. Kok H, Kuh D, Cooper R, et al. Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause 2006;13:19-27.
26. Nappi RE, Sinforiani E, Mauri M, Bono G, Polatti F, Nappi G. Memory functioning at menopause: impact of age in ovariectomized women. Gynecol Obstet Invest 1999;47:29-36.
27. Verghese J, Kuslansky G, Katz MJ, et al. Cognitive performance in surgically menopausal women on estrogen. Neurology 2000;55:872-874.
28. McLay RN, Maki PM, Lyketsos CG. Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatry Clin Neurosci 2003;15:161-167.
29. Gregoire J, Van der Linden M. Effects of age on forward and backward digit spans. Aging Neuropsychol Cogn 1997;4:140-149.
30. Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G. Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci 1987;8:537-548.
31. Strauss E, Sherman EM, Spreen O. A Compendium of Neuropsychological Tests. New York: Oxford University Press, 2006.
32. Maki PM. Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience 2006;138:1027-1030.
33. Sherwin BB. The critical period hypothesis: can it explain discrepancies in the estrogen-cognition literature? J Neuroendocrinol 2006;19:77-81.
34. Tombaugh TM, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-935.
35. Warren MP, Halpert S. Hormone replacement therapy: controversies, pros and cons. Best Pract Res Clin Endrocrinol Metab 2004;18:317-332.
36. Bender CM, Paraska KK, Sereika SM, Ryan CM, Berga SL. Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review. J Pain Symptom Manage 2001;21:407-424.
37. Poniatowski BC, Grimm P, Cohen G. Chemotherapy-induced menopause: a literature review. Cancer Invest 2001;19:641-648.
38. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000;18:2695-2701.
39. Schagen SB, van Dam FSAM, Muller MJ, Boorgerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999;85:640-650.
40. van Dam FSAM, Schagen S, Muller MJ, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210-218.
41. Donovan K, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 2005;104:2499-2507.
42. Tchen N, Juffs HG, Downie FP, et al. Cognitive function, fatigue and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003;21:4175-4183.
43. Jenkins V, Shilling V, Deutsch G, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006;94:828-834.
44. Hermelink K, Untch M, Lux MP, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer. Results of a prospective, multicenter, longitudinal study. Cancer 2007;109:1905-1913.
45. Wefel JS, Lenzi R, Theriault R, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast cancer. Results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-2299.
46. Schagen SB, Muller MJ, Boogerd W, et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 2002;13:1387-1397.
47. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D. The effects of adjuvant chemotherapy on cognition in women with breast cancer-preliminary results of an observational longitudinal study. Breast 2005;14:142-150.
48. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. 'Chemobrain' in breast carcinoma? A prologue. Cancer 2004;101:466-475.
49. Vardy J, Tannock I. Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 2007;63:183-202.
50. Drake EB, Henderson V, Stanczyk FZ, et al. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 2000;54:599-602.
51. Maki P, Hogervorst E. HRT and cognitive decline. Best Pract Res Clin Endocrinol Metab 2003;17:105-122.
52. Shilling V, Jenkins V, Fallowfield L, Howell T. The effects of hormone therapy on cognition in breast cancer. J Steroid Biochem Mol Biol 2003;86:405-412.